Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Amgen Stock Was Sickly Today


Investors are often encouraged when one of their companies bulks up by acquiring a peer. But that sentiment can turn sour if the takeover target stumbles.

This was the impetus behind 's (NASDAQ: AMGN) nearly 3% decline on the stock market Wednesday. After divulging its latest quarterly results, the peer it plans to walk to the altar with wasn't looking very pretty.

That potential Amgen asset is pharmaceutical company Horizon Therapeutics (NASDAQ: HZNP), which published its first-quarter figures before market open.

Continue reading


Source Fool.com

Amgen Inc. Stock

€355.40
1.250%
There is an upward development for Amgen Inc. compared to yesterday, with an increase of €4.40 (1.250%).
With 41 Buy predictions and 4 Sell predictions Amgen Inc. is one of the favorites of our community.
However, we have a potential of -5.46% for Amgen Inc. as the target price of 336 € is below the current price of 355.4 €.
Like: 0
Share

Comments